Nocion Therapeutics
About Nocion Therapeutics
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series B T: - FT: Series B |
A: 70000000 MR: - FA: $70M FAN: 70000000 |
D: 2024-04-02 FD: 2024-04-02 |
3 investors |
| 2 |
RT: Series B T: - FT: Series B |
A: 62000000 MR: - FA: $62 million FAN: 62000000 |
D: 2024-03-04 FD: 2024-03-04 |
7 investors |
Growth Metrics
Team & Leadership
Matthew Frankel
Chief Medical Officer
Richard P. Batycky
President and Chief Executive Officer
Peter Courossi
Acting Chief Financial Officer
James L. Ellis
Chief Scientific Officer
Joan E. Shaw
Senior Vice President, Clinical Operations
Clifford Woolf
Professor in Neurology and Neurobiology
Recent News
Nocion Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- nociontx.com
- Industries
- Biopharmaceutical
- Company Size
- ~440 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro